Artículo
Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
Autor/es | Sicras Mainar, Antoni
Morillo Verdugo, Ramón Alejandro ![]() ![]() ![]() ![]() ![]() ![]() |
Departamento | Universidad de Sevilla. Departamento de Farmacología |
Fecha de publicación | 2020 |
Fecha de depósito | 2023-11-03 |
Publicado en |
|
Resumen | To identify potential drug interactions (DIs) between pangenotypic direct-acting antivirals (pDAAs) and concomitant cardiovascular (CV) therapies in patients with chronic hepatitis C (CHC). |
Cita | Sicras Mainar, A. y Morillo Verdugo, R.A. (2020). Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection. Journal of International Medical Research, 48 (10), 0300060520964659. https://doi.org/10.1177/0300060520964659. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
sicras-mainar-morillo-verdugo- ... | 495.6Kb | ![]() | Ver/ | |